english.prescrire.org > Spotlight > 100 most recent > Covid-19 : Follow Prescrire's independent, evidence-based analysis of the pandemic

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent : 1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Spotlight

Covid-19 : Follow Prescrire's independent, evidence-based analysis of the pandemic

COVID-19 Prescrire's editors are publishing an ongoing series of news updates featuring independent analysis of developments related to the covid-19 pandemic. Useful and practical information, to help healthcare professionals gain a clear and balanced view.

"Covid-19 and severe breathing problems: dexamethasone reduced mortality in one trial" (24 June 2020) > HERE
"Lack of access to drug evaluation data: a recurrent problem, not confined to covid-19" (8 June 2020) > HERE
"Covid-19 and hydroxychloroquine (Plaquenil°): new data show no evidence of efficacy" (16 April 2020) > HERE
"New data on the cardiac adverse effects of the combination of hydroxychloroquine (Plaquenil°) with azithromycin (Zithromax° or other brands)" (16 April 2020) > HERE
"Covid-19 and hydroxychloroquine (Plaquenil°): still no conclusive results" (15 April 2020) > HERE
"Covid-19 and hydroxychloroquine: uncertainties and unanswered questions" (2 April 2020) > HERE
"Covid-19 and hydroxychloroquine: caution" (30 March 2020) > HERE
"Covid-19 and drug trials: what to make of the initial results?" (23 March 2020) > HERE
For more information in French, see www.prescrire.org > Dans l'actualité

©Prescrire 24 June 2020

For more updates, follow us on Facebook and Twitter

Keep up with the latest from Prescrire's editors, and support our values of independence and quality information, first and foremost in the interest of patients. > Follow us on Facebook or > Follow us on Twitter

Enjoy full access to Prescrire International, and support independent information

Subscribe now

Share

Read more:

All the subjects in
Prescrire's Spotlight
Free >